CRYSTAL NELSON: Open Payments
NPI 1437356870 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 31 payments from 13 companies in 2025. Trend: 2023 $397 · 2024 $488 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $210 |
| Tris Pharma Inc | 3 | $59 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Neos Therapeutics, LP | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Corium, LLC | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VRAYLAR, Auvelity, Onyda XR, REXULTI, Azstarys, SPRAVATO, Adzenys XR-ODT, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
